Glimizest MV 2mg/500mg/0.2mg Tablet
By Glimizest MV
Rx
10 Tablet in a Strip

Composition
Glimepiride(2mg) + Metformin(500mg) + Voglibose(0.2mg)

Manufacturer - Alniche Life Sciences Pvt Ltd
Alniche Life Sciences Pvt. Ltd., S-14, 2nd Floor, Janta Market Rajouri Garden, New Delhi – 110 027

Expires on or after
September, 2025

liver
When using Glimizest MV 2mg/500mg/0.2mg Tablet, it is important to be cautious if you have liver disease. Your doctor may need to adjust the dosage accordingly, so it's best to consult with them before starting this medication. Typically, Rozmet Trio is initiated at a low dose for individuals with mild to moderate liver issues. However, it is not advisable to use this tablet if you have severe liver disease. If you have any concerns or liver-related issues, it's crucial to seek guidance from your healthcare provider before taking Glimizest MV 2mg/500mg/0.2mg Tablet.

kidney
Glimizest MV 2mg/500mg/0.2mg Tablet should be avoided if you have kidney disease. Consult your doctor before use. Not recommended for severe kidney disease.

alcohol
Avoid consuming alcohol while taking Glimizest MV 2mg/500mg/0.2mg Tablet.

driving
Avoid driving if you experience symptoms of low or high blood sugar while taking Glimizest MV 2mg/500mg/0.2mg Tablet, as it may affect your ability to drive safely.

pregnancy
Glimizest MV 2mg/500mg/0.2mg Tablet may not be safe during pregnancy. Animal studies suggest potential harm to the baby. Your doctor will assess risks versus benefits before prescribing. Consult your doctor before use.

breastfeeding
Glimizest MV 2mg/500mg/0.2mg Tablet is likely unsafe while breastfeeding. Limited data indicates the drug can pass into breastmilk and potentially harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹135
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024